Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study

Layton, A. M.; Schaller, M.; Homey, B.; Hofmann, M. A.; Bewley, A. P.; Lehmann, P.; Nohlgard, C.; Sarwer, D. B.; Kerrouche, N.; Ma, Y. M.

dc.contributor.author	Schaller, Martin
dc.date.accessioned	2016-08-30T10:53:04Z
dc.date.available	2016-08-30T10:53:04Z
dc.date.issued	2015
dc.identifier.issn	1468-3083
dc.identifier.uri	http://hdl.handle.net/10900/71920
dc.language.iso	en	de_DE
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/jdv.13305	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Brimonidine gel 0.33% rapidly improves patient-reported outcomes by controlling facial erythema of rosacea: a randomized, double-blind, vehicle-controlled study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160427062602_00197
utue.publikation.seiten	2405-2410	de_DE
utue.personen.roh	Layton, A. M.
utue.personen.roh	Schaller, M.
utue.personen.roh	Homey, B.
utue.personen.roh	Hofmann, M. A.
utue.personen.roh	Bewley, A. P.
utue.personen.roh	Lehmann, P.
utue.personen.roh	Nohlgard, C.
utue.personen.roh	Sarwer, D. B.
utue.personen.roh	Kerrouche, N.
utue.personen.roh	Ma, Y. M.
dcterms.isPartOf.ZSTitelID	Journal of The European Academy of Dermatology and Venereology	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	29	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE